Japanese Epidemiologic Study for Perioperative Anaphylaxis

Conditions

anaphylaxis

Kabasawa Y, Takazawa T, Shiraishi T, Kanemaru E, Tuji T, Sakimura S, Saito S.

2026-03-18

The Japanese Epidemiologic Study for Perioperative Anaphylaxis, a prospective nationwide study: allergen exposure, epidemiology, and diagnosis of anaphylaxis during general anaesthesia

Tomonori Takazawa, Tatsuo Horiuchi, Kazuhiro Nagumo, Yuki Sugiyama, Tsubasa Akune et al. (34 authors)

British Journal of Anaesthesia2023-03-2746 citations

10.1016/j.bja.2023.02.018

The Japanese Epidemiologic Study for Perioperative Anaphylaxis, a prospective nationwide study: clinical signs, severity, and therapeutic agents

Yuki Sugiyama, Tomonori Takazawa, Natsuko Watanabe, Kiyoko Bito, Tetsuhiro Fujiyoshi et al. (21 authors)

British Journal of Anaesthesia2023-03-2418 citations

10.1016/j.bja.2023.02.023

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) The patient whose consent has been obtained in writing with respect to participation in this study 2) The patient showing Grade 2 or severer anaphylactic reactions during perioperative period. In the medical institutions conducting research A only, the subject will be patient showing Grade 3 or severer anaphylactic reactions

Exclusion criteria

Exclusion criteria: 1) The patient who did not give consent for participation 2) The patient who use or have a plan to use unapproved drugs such as investigational drugs 3) The patient to whom a doctor judged inappropriate for participating in this study

Design outcomes

Primary

Measure	Time frame
Identification of causative drug(s) of perioperative anaphylaxis	—

Secondary

Measure	Time frame
Incidence and severity of perioperative anaphylaxis	—

Countries

Japan

Contacts

Public ContactTomonori Takazawa

Gunma University Hospital Intensive Care Unit

takazawt@gunma-u.ac.jp027-220-8698

Outcome results